Literature DB >> 2787800

Effects of growth hormone therapy on circadian osteocalcin rhythms in idiopathic short stature.

M E Markowitz1, J DiMartino-Nardi, F Gasparini, K Fishman, J F Rosen, P Saenger.   

Abstract

The effects of GH administration on the circadian osteocalcin (Oc) rhythm were determined in four prepubertal children with idiopathic short stature (height, less than 5th percentile; growth velocity, less than 50th percentile for age). Each child underwent 24-h sequential blood sampling on three occasions: immediately before the initiation of GH treatment, 6 months later, and at the end of 12 months of treatment. The growth rate increased more than 50% over baseline in three of the four children during at least one of the 6-month periods. Insulin-like growth factor-I levels increased during treatment in all of the children. Twenty-four-hour Oc levels increased on 7 of the 8 treatment days evaluated. When mean 24-h Oc patterns for each of the 3 study days were derived by averaging across individual subjects at each time point and then compared, we noted an upward shift in the entire pattern during treatment (t = 13.2 at P less than 0.001 and t = 5.9 at P less than 0.001 for 6 and 12 month comparisons vs. the pretreatment day, respectively). This was more easily appreciated after the data were smoothed using the method of running means. There was, in addition, a progressive improvement in the shape of the Oc pattern compared to a normative model derived from a study of healthy adult men. The correlation between the model and the pre-GH day was 0.46, that between the model and the 6 months of GH day was 0.77, and that between the model and the 12 months of GH day was 0.96. Cross-correlation analyses showed that the peak correlation between the 2 treatment days and the model occurred at zero lag. In contrast, the peak correlation between the pre-GH day and the model or the pre-GH day and either of the 2 treatment days occurred when the pre-GH series was lagged by 2-3 h. Thus, an additional finding is the synchronization of the Oc series that occurred during treatment. We conclude that GH treatment increases Oc concentrations in children with idiopathic short stature by affecting its circadian rhythm. This rise in Oc values may not necessarily reflect an increase in growth velocity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2787800     DOI: 10.1210/jcem-69-2-420

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

1.  Does growth hormone influence the severity of phosphopenic rickets?

Authors:  T Bistritzer; S A Chalew; A Hanukoglu; K M Armour; P J Haney; A A Kowarski
Journal:  Eur J Pediatr       Date:  1990-11       Impact factor: 3.183

2.  Serum osteocalcin and bone isoenzyme alkaline phosphatase in growth hormone-deficient patients: dose-response studies with biosynthetic human GH.

Authors:  H K Nielsen; J O Jørgensen; K Brixen; J S Christiansen
Journal:  Calcif Tissue Int       Date:  1991-02       Impact factor: 4.333

3.  Diurnal rhythm and 24-hour integrated concentrations of serum osteocalcin in normals: influence of age, sex, season, and smoking habits.

Authors:  H K Nielsen; K Brixen; L Mosekilde
Journal:  Calcif Tissue Int       Date:  1990-11       Impact factor: 4.333

Review 4.  Structures and molecules involved in generation and regulation of biological rhythms in vertebrates and invertebrates.

Authors:  S Binkley
Journal:  Experientia       Date:  1993-08-15

Review 5.  Renal effects of growth hormone. II. Electrolyte homeostasis and body composition.

Authors:  G D Ogle; A R Rosenberg; G Kainer
Journal:  Pediatr Nephrol       Date:  1992-09       Impact factor: 3.714

6.  Diurnal rhythm in serum osteocalcin: relation with sleep, growth hormone, and PTH(1-84).

Authors:  H K Nielsen; K Brixen; M Kassem; S E Christensen; L Mosekilde
Journal:  Calcif Tissue Int       Date:  1991-12       Impact factor: 4.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.